SAMP VISION AND MISSION STATEMENT 2.1 Vision. The

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
SAMP VISION AND MISSION STATEMENT
2.1 Vision. The objectives for “Pho House Dallas” for the first five years of operation is:
a. Grow 10 locations within the first five years.
b. Keep food costs below 35% of revenue.
c. Keep employee labor costs between 16-18% of revenue.
d. Maintain tight controls on cost and operations through partnership management.

2.2 Mission. The Pho House Dallas will strive to be the premier specialty restaurant in the Northeast Heights of Dallas, Texas. We want our guest to have the total experience of the Euro Asian, not only with a great meal, but also be provided with the atmosphere. We will be doing unique things, such as Sunday brunches, and Euro Asian Festival and Holiday celebration. Our focus will be concentrate on four major areas:

a. We will serve quality food for a competitive price, with a large selection of Euro Asian Cuisine.
b. Our customer service support will show that we want to be the restaurant of choice for families and singles, young and old, male and female.
c. Employee welfare will be equally important to our success. We want our employees to feel as a part of the success of The Pho House Dallas. Happy employees make happy guests.
d. We will combine menu variety, atmosphere, ambiance, and friendly service to create a sense of “place” in order to reach our goals.

2.3 Competitive Advantage. The Pho House Dallas will have the competitive advantage of being the only restaurant within the largest populated county of Texas with the “uniqueness” of Euro Asian hospitality. The foods and atmosphere of the Pho House Dallas will draw patron for their first visit, through curiosity alone. The service and quality of the food will assist in the formulation of “regulars” and referrals. At this time, there are no restaurants with “Trendy” atmospheres serving this population (1,300,000 +).

USA Restaurant Funding Inc. (USAR) Stock Research Links

USAR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 201

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 216

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 200

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 118

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 136

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 53

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Sentiment Shifts: Spotlight on Key Stocks with Puts

Updated Category News Views 232

Understanding Investor Sentiment Through Options Activity In the world of stock trading, monitoring investor sentiment is crucial. Retail investors frequently evaluate market movements based on buying and selling patterns. Yet, these activities can often mislead people about the true motivations behind traders' decisions. For example, purchasing shares may suggest...

Continue Reading
Solana Price Overview: Recent Trends and Market Insights

Updated Category News Views 50

Understanding Solana's Recent Price Behavior Solana's price has recently faced a decline of 3.66% within a 24-hour timeframe, settling at $150.80. Despite this short-term drop, its performance over the past week shows a more optimistic trend with a 5.0% increase from a previous value of $145.79. This fluctuation showcases the volatility often associated with...

Continue Reading
Navigating Market Cycles: Insights on E-Mini S&P 500 Movements

Updated Category News Views 216

Understanding the Current Market Cycle Dynamics The landscape of the E-Mini S&P 500 marks an intriguing phase as we enter the final quadrant of the master cycle that commenced with a significant low. This stage, specifically noted as the range of 270° to 360°, is where crucial market movements crystallize, setting the stage for prospective outcomes. As we analyze chart...

Continue Reading
Edgewell Personal Care Reports Q1 2025 Financial Performance

Updated Category News Views 297

Overview of Q1 Fiscal 2025 Results Edgewell Personal Care Company (NYSE: EPC) recently released its financial results for the first quarter of fiscal 2025, revealing a net sales figure of $478.4 million, representing a decrease of 2.1% compared to the same quarter last year. The decline reflects a 1.3% decrease in organic net sales, which excludes the effects of currency...

Continue Reading
Rockwell Automation Exceeds Expectations in Fiscal Q1 2025

Updated Category News Views 412

Rockwell Automation Sees Strong First Quarter Performance Rockwell Automation, Inc. (NYSE: ROK) has announced its fiscal Q1 2025 results, showcasing a remarkable performance that exceeded market expectations. Under the leadership of Blake Moret, Chairman and CEO, the company reported a combination of improved margins and earnings per share (EPS) this quarter, attributed...

Continue Reading